Navigation Links
"The State of the Medical Marijuana Markets 2011" First Ever Investor-Grade Analysis Report of the Marijuana Marketplace in the United States
Date:3/24/2011

WASHINGTON, March 24, 2011 /PRNewswire/ -- Medical marijuana is now a $1.7 billion market, according to a new report released today by See Change Strategy LLC, an independent financial analysis firm that specializes in new and unique markets. To put that number in perspective, it will soon rival the annual sales of Viagra.

The report draws on more than 300 survey responses and dozens of interviews with market participants and resulted in the following findings:

24.8 million people are eligible to receive a recommendation and purchase marijuana legally under state laws, and approximately 730,000 people actually do.

Medical marijuana markets exist in seven states (California, Colorado, Michigan, Montana, Oregon, Washington and New Mexico) and will open this year in five more (Arizona, Maine, New Jersey, Rhode Island and the District of Columbia).  

Current marijuana markets will double in the next five years. The two major drivers of growth will be patient access (the number of legal patients will rise) and regulatory clarity (states will adopt regulation and license processes that facilitate the sale of medical marijuana).

"Medical marijuana markets are rapidly growing across the country and will reach $1.7 billion this year," said Ted Rose, editor of the report.  "We undertook this effort because we noticed a dearth of reliable market information about this politically charged business."

"Hundreds of businesses exist around the country that cultivate and sell marijuana to customers. Many of these businesses emerged in the wake of the Obama Administration's decision to deprioritize federal prosecutions of individuals and business complying with state medical marijuana laws. The State of the Medical Marijuana Markets 2011 shows which states represent the most active markets, who is making money, and how are they doing it," said Rose.

The report, which contains proprietary information on the size, saturation, and potential of markets, as well as basic business models and financing options, is available for $1,150.

Visit www.medicalmarijuanamarkets.com for the Executive Summary and Methodology.


'/>"/>
SOURCE See Change Strategy LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
4. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
10. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
11. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , May 27, 2016  A new study highlights the necessity of health literacy ... Journal of the American College of Radiology , a majority of oncology patients undergo ... Photo - http://photos.prnewswire.com/prnh/20160527/373022 ... ... Medical Diagnostic Imaging Ampronix ...
(Date:5/27/2016)... Israel , May 27, 2016 ... an innovative biopharmaceutical company focused on late-stage drug ... Dexcel Pharma of pivotal batches required ... and Drug Administration (FDA). This follows Kitov,s ... Phase III trial successfully met its primary efficacy ...
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... June 01, 2016 , ... Psoriasis: Targets ... risks ”. , As corresponding author Professor Luigi Naldi says “The review in ... and psoriasis. Smoking influences the onset and the severity of psoriasis, and negatively ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... announced it has been included by Gartner, Inc. in the Contact Center Infrastructure ... of Contact Center Infrastructure technologies, some of which include: Computer-telephony integration (CTI)/Web ...
(Date:5/31/2016)... Walton Beach, Florida (PRWEB) , ... May 31, ... ... technology to Jay Butch of CertainTeed Corporation, he knew it was something that ... is as state-of-the-art and cutting-edge as it gets,” says Butch, CertainTeed’s Director of ...
(Date:5/31/2016)... , ... May 31, 2016 , ... The successful implementation ... in their laboratories as well. However, laboratories have different challenges compared to manufacturing environments. ... lean operations in the lab, METTLER TOLEDO has developed the Lean Lab Checklist ...
(Date:5/31/2016)... ... May 31, 2016 , ... Spectrum Aquatics has launched a brand new ADA ... and built with the user in mind. , “Over the last two years our ... an ADA 400 lbs lift is a necessary requirement for certain facilities with specific ...
Breaking Medicine News(10 mins):